Tag: KGAA
Merck KGaA: price target raised at UBS
(CercleFinance.com) – UBS reaffirms its ‘buy’ recommendation on Merck KGaA with a price target raised from 172 to 186 euros, a new target which contains 17% upside potential for the…
Merck KGaA: Michael Kleinemeier appointed interim president
(CercleFinance.com) – The German chemicals and pharmaceuticals group Merck announced on Thursday the appointment of Michael Kleinemeier, a former SAP executive, as chairman of its supervisory board for a temporary…
Merck KGaA suffers major blow as multiple sclerosis drug fails in late-phase trials – 12/05/2023 at 11:03 p.m.
(Rewrites on all levels) by Ludwig Burger Germany’s Merck KGaA MRCG.DE said its experimental multiple sclerosis drug evobrutinib failed to meet the primary goal in highly anticipated late-stage trials, dealing…
Merck KGaA suffers major blow as multiple sclerosis drug fails in late-phase trials – 06/12/2023 at 00:00
(Adds details on pharmaceutical unit results in paragraph 12, as well as information on group performance in last two paragraphs) by Ludwig Burger Germany’s Merck KGaA MRCG.DE said its experimental…
Merck KgaA: Stifel remains at ‘buy’ and lowers its target
(CercleFinance.com) – Stifel maintains its ‘buy’ rating on Merck KgaA shares, with a price target reduced from 193.5 to 182 euros. The analyst indicates that Merck is rather pessimistic about…
Merck KGaA: strategic partnership with the Chinese Hengrui
(CercleFinance.com) – Merck KGaA announced on Monday the conclusion of a strategic collaboration agreement with the Chinese company Hengrui, with which it intends to develop a PARP inhibitor and an…
Merck KGaA: Extended collaboration with start-up Quris-AI
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Merck KGaA: Two partnerships concluded in AI
(CercleFinance.com) – The German pharmaceutical group Merck KGaA announced on Wednesday that it had signed two strategic collaboration agreements with a view to accelerating the development of new drugs using…
Merck KGaA: License agreement with PDS Biotech
(CercleFinance.com) – The American company PDS Biotechnology announced on Tuesday the signing of a worldwide license agreement with the German pharmaceutical group Merck, from which it will resume the development…
Merck KGaA: license agreement with PDS Biotech
(CercleFinance.com) – The American company PDS Biotechnology announced on Tuesday the signing of a worldwide license agreement with the German pharmaceutical group Merck, from which it will resume the development…
Merck KGaA: The R&D day struggles to convince
(CercleFinance.com) – Merck KGaA announced on Monday that it intended to double the productivity of its research and development (R&D) activities in oncology, neurology and immunology. The German biopharmaceutical group…
BIOCORP and MERCK KGAA, Darmstadt, Germany, sign a new partnership for smart drug delivery – 10/10/2022 at 07:30
• BIOCORP and Merck KGaA, Darmstadt, Germany, partner for the development and worldwide distribution of a specific version of Mallya for drug delivery devices • BIOCORP and Merck KGaA, Darmstadt,…